Hudson Bay Capital Management’s AbbVie ABBV Stock Holding History

Hudson Bay Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-56,200	Closed	-$10.4M	–	1203
2025 Q2	$10.4M	Sell	56,200 -647,700	-92%	-$120M	0.04%	348
2025 Q1	$147M	Buy	+703,900	New	+$137M	0.45%	48
2024 Q2	–	Sell	-200,000	Closed	-$36.4M	–	761
2024 Q1	$36.4M	Buy	+200,000	New	+$34.5M	0.2%	68
2017 Q2	–	Sell	-50,000	Closed	-$3.26M	–	514
2017 Q1	$3.26M	Buy	50,000 +25,000	+100%	+$1.57M	0.04%	353
2016 Q4	$1.57M	Buy	+25,000	New	+$1.53M	0.03%	399

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hudson Bay Capital Management's ABBV Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in AbbVie (ABBV) in Q1 2026: 20,010 shares worth $4.35M. The stake represents 0.02% of the portfolio and ranks #556 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in ABBV as recently as Q3 2025.

Hudson Bay Capital Management first reported a position in ABBV in Q3 2014 and has held it in 15 quarters since. The position peaked at $136M in Q1 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Hudson Bay Capital Management held 20,010 shares of AbbVie worth $4.35M as of Q1 2026.
AbbVie was a new Hudson Bay Capital Management position in Q1 2026.
AbbVie made up 0.02% of Hudson Bay Capital Management's portfolio in Q1 2026, its #556 holding.
Hudson Bay Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 15 quarters since.
Hudson Bay Capital Management's AbbVie position peaked at $136M in Q1 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.